Who We Invest In
Built for Founders Solving Real Healthcare Problems
HIP backs teams operating at the intersection of clinical relevance, commercial viability, and near-term adoption.
We Are a Strong Fit If You Are
- Developing healthcare, biotech, medtech, diagnostics, or care delivery innovations
- Focused on provider adoption, patient proximity, or care decentralization
- Seed to Series B stage
- Capital-efficient with a clear path to validation
- Navigating areas that are currently underfunded or overlooked
We partner with disciplined, mission-driven founders building practical healthcare innovation.
We Are Not a Fit For
- Pure consumer wellness
- Long-horizon moonshots without a path to adoption
- Teams without domain or clinical insight
We avoid categories misaligned with near-term clinical impact and adoption.
Stage & Approach
- Seed, Series A, and Series B focus
- Clear validation milestones
- Adoption-driven thesis
We invest early, with discipline and conviction, prioritizing validation over hype.
Before You Submit
What You Should Know
Our Focus Areas
Where we’re leaning in.
- Care delivery closer to the patient
- Diagnostics and decision support
- Platform technologies with clear healthcare integration
- Solutions improving provider efficiency and patient outcomes
- Technologies underserved by traditional venture or shifting grant priorities
If your market is being ignored because it’s “not trendy enough,” we want to talk.
How We Invest
What to expect.
- Stage: Seed – Series B
- Initial Check Size: $3M – $7M
- Structure: Prefer lead investor
- Geography: North America focused
We value clarity over hype, evidence over buzz, and progress over promises.
Our Process Is Simple
- Submit your pitch
- Initial review by the investment team
- Focused diligence on technology/science, technology/science adoption, market, and execution
- Clear yes/no decision
No endless loops. No vague maybes.